Auris Medical Holding (EARS) Reports Q4 Loss of CHF0.16/Share
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/20/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Jefferies Cuts Price target on Auris Medical Holding (EARS) Following 4Q
March 15, 2016 8:30 AM EDTJefferies maintained a Buy rating on Auris Medical Holding AG (NASDAQ: EARS), and cut the price target to $8.00 (from $12.00), following the company's 4Q. Although management continues to see enrollment completion for TACTT2 this month, the topline results for both TACTT trials are... More
